Find Xanomeline manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 131986-45-3, 3-(hexyloxy)-4-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazole, Ly 246708, Ly-246708, Ly246708, 3-hexoxy-4-(1-methyl-3,6-dihydro-2h-pyridin-5-yl)-1,2,5-thiadiazole
Molecular Formula
C14H23N3OS
Molecular Weight
281.42  g/mol
InChI Key
JOLJIIDDOBNFHW-UHFFFAOYSA-N
FDA UNII
9ORI6L73CJ

Xanomeline
Xanomeline is under investigation in clinical trial NCT02831231 (Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium).
1 2D Structure

Xanomeline

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-hexoxy-4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazole
2.1.2 InChI
InChI=1S/C14H23N3OS/c1-3-4-5-6-10-18-14-13(15-19-16-14)12-8-7-9-17(2)11-12/h8H,3-7,9-11H2,1-2H3
2.1.3 InChI Key
JOLJIIDDOBNFHW-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCCCCCOC1=NSN=C1C2=CCCN(C2)C
2.2 Other Identifiers
2.2.1 UNII
9ORI6L73CJ
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (3-o-hexyloxy)-tztp

2. 3-(3-o-hexyl-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine

3. Ly 246708

4. Ly-246708

5. Ly246708

6. Xanomeline Tartrate

2.3.2 Depositor-Supplied Synonyms

1. 131986-45-3

2. 3-(hexyloxy)-4-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazole

3. Ly 246708

4. Ly-246708

5. Ly246708

6. 3-hexoxy-4-(1-methyl-3,6-dihydro-2h-pyridin-5-yl)-1,2,5-thiadiazole

7. 9ori6l73cj

8. Chembl21536

9. 5-(4-hexyloxy-[1,2,5]thiadiazol-3-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine

10. Chebi:10056

11. Ly-246708 Free Base

12. 5-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-1-methyl-1,2,3,6-tetrahydropyridine

13. Xanomeline (usan)

14. Xanomeline [usan]

15. Pyridine, 3-(4-(hexyloxy)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methyl-

16. Xanomeline [usan:inn]

17. Unii-9ori6l73cj

18. Lumeron

19. Memcor

20. Hexyloxy-tztp

21. Pyridine, 3-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-1,2,5,6-tetrahydro-1-methyl-

22. Xanomeline [mi]

23. Xanomeline [inn]

24. Gtpl57

25. 3-(4-(hexyloxy)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine

26. Xanomeline [mart.]

27. Xanomeline [who-dd]

28. Schembl121046

29. Dtxsid60157286

30. Bcp31492

31. Ex-a6592

32. Zinc1532358

33. Bdbm50003359

34. Mfcd00867179

35. Akos016007489

36. Db15357

37. Sb18821

38. Nnc-11-0232

39. Ds-15663

40. Hy-105182

41. Cs-0025224

42. Ft-0602214

43. C72296

44. D06330

45. A888347

46. L000694

47. Q8042940

48. Ly-246708; Ly246708; Ly 246708

49. 3-(4-hexoxy-1,2,5-thiadiazol-3-yl)-1-methyl-5,6-dihydro-2h-pyridine

50. 3-(4-hexyloxy-1 ,2,5-thiadiazol-3-yl)-1 ,2,5,6-tetrahydro-1-methyl-pyridine

51. 5-(4-hexyloxy-[1,2,5]thiadiazol-3-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine; Oxalic Acid

52. 5-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-1-methyl-1,2,3,6-tetrahydropyridine, Aldrichcpr

53. 1018845-70-9

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 281.42 g/mol
Molecular Formula C14H23N3OS
XLogP33.3
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count5
Rotatable Bond Count7
Exact Mass281.15618354 g/mol
Monoisotopic Mass281.15618354 g/mol
Topological Polar Surface Area66.5 Ų
Heavy Atom Count19
Formal Charge0
Complexity298
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Muscarinic Agonists

Drugs that bind to and activate muscarinic cholinergic receptors (RECEPTORS, MUSCARINIC). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate. (See all compounds classified as Muscarinic Agonists.)


Parasympathomimetics

Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. (See all compounds classified as Parasympathomimetics.)


Psychotropic Drugs

A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). (See all compounds classified as Psychotropic Drugs.)


API SUPPLIERS

read-more
read-more

01

Raghava Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering
Not Confirmed
arrow

02

FandaChem

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering
Not Confirmed
arrow

FandaChem

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Antibody Engineering
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

03

BOC Sciences

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering
Not Confirmed
arrow

BOC Sciences

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Antibody Engineering
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

04

Hunan Huateng Pharmaceutical Co lt...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering
Not Confirmed
arrow

Hunan Huateng Pharmaceutical Co lt...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Antibody Engineering
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

05

SimSon Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering
Not Confirmed
arrow

06

Alfa Chemicals

United Kingdom

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering
Not Confirmed
arrow

Alfa Chemicals

United Kingdom

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Antibody Engineering
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-more

01

arrow
CPHI Middle east
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNeuland Laboratories- A dedicated 100% API provider.

Flag India
Digital Content Digital Content

XANOMELINE TARTRATE

NDC Package Code : 58032-3003

Start Marketing Date : 2023-03-17

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Neuland
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

Alfa Chemicals

United Kingdom
CPHI Middle east
Not Confirmed
arrow

Alfa Chemicals

United Kingdom
arrow
CPHI Middle east
Not Confirmed

xanomeline tartrate

About the Company : Alfa Chemicals offers an all-encompassing range of solutions to the global pharmaceutical market, including contract manufacturing for intermediates & APIs; supply chain consolidat...

Alfa Chemicals offers an all-encompassing range of solutions to the global pharmaceutical market, including contract manufacturing for intermediates & APIs; supply chain consolidation; unique and tailored pharmaceutical APIs; excipients; plus bespoke buffer solutions.
blank

02

BOC Sciences

U.S.A
CPHI Middle east
Not Confirmed
arrow

BOC Sciences

U.S.A
arrow
CPHI Middle east
Not Confirmed

Xanomeline

About the Company : BOC Sciences is a brand of BOCSCI Inc. We leverage our wide spectrum of business in the fields of development, manufacturing, marketing, and distribution to help you make best-info...

BOC Sciences is a brand of BOCSCI Inc. We leverage our wide spectrum of business in the fields of development, manufacturing, marketing, and distribution to help you make best-informed decisions tailored to your evolving needs for premium chemicals. Our complete suite of CRO services spans the entire molecule development pipeline including contract research for target identification, building blocks, compound synthesis, biochemical and cellular analysis, preclinical animal tests, and clinical studies.
blank

03

FandaChem

China
CPHI Middle east
Not Confirmed
arrow

FandaChem

China
arrow
CPHI Middle east
Not Confirmed

xanomeline tartrate

About the Company : FandaChem, headquartered in Hangzhou, China, is a reputable supplier and exporter of chemicals with a focus on delivering high-quality products. Our expertise lies in exporting a w...

FandaChem, headquartered in Hangzhou, China, is a reputable supplier and exporter of chemicals with a focus on delivering high-quality products. Our expertise lies in exporting a wide range of superior chemicals, specializing in areas such as agrochemicals, flavors, fragrances, pharmaceuticals, intermediates, paints, resins, plastics, surfactants, polymers, cosmetics, and more. Dedicated to being your dependable partner in China, FandaChem is devoted to offering top-notch products, competitive prices, and excellent service to meet the needs of our customers.
blank

04

CPHI Middle east
Not Confirmed
arrow
arrow
CPHI Middle east
Not Confirmed

Xanomeline

About the Company : Hunan Huateng Pharmaceutical Co., Ltd. is a research-based manufacturer and supplier of combinatorial building blocks, organics and fine chemicals, with 5000m2 laboratory and over ...

Hunan Huateng Pharmaceutical Co., Ltd. is a research-based manufacturer and supplier of combinatorial building blocks, organics and fine chemicals, with 5000m2 laboratory and over 100 experienced chemists. Huateng is dedicated to bring high quality and cost effective chemical products and services to our clients. Our versatile chemical synthesis expertise and manufacturing capability prepare us to produce a variety of known, novel or even hard-to-find chemicals from kg to ton scale.
blank

05

CPHI Middle east
Not Confirmed
arrow
arrow
CPHI Middle east
Not Confirmed

xanomeline tartrate

About the Company : Raghava Life Sciences Pvt. Ltd. (RLS), established in the year 2018, is an integrated small molecules chemistry Contract research, Development and Manufacturing Organization (CDMO)...

Raghava Life Sciences Pvt. Ltd. (RLS), established in the year 2018, is an integrated small molecules chemistry Contract research, Development and Manufacturing Organization (CDMO). RLS is offering chemistry services to clients across the globe.RLS is a technology driven organization with a flexible approach and expertise in Custom chemical synthesis, Process Research & Development and Scale-up. RLS main focus is Contract Research And Manufacturing Services (CRAMS) to support innovator companies/business partners globally. We develop and manufacture high quality generic Active Pharmaceutical Ingredients (APIs) for formulation companies
blank

06

CPHI Middle east
Not Confirmed
arrow
arrow
CPHI Middle east
Not Confirmed

xanomeline tartrate

About the Company : "SimSon Pharma, a renowned name in pharmaceutical sector, has build high its reputation as a complete solution provider in contract research arena. We are leading manufacturer and ...

"SimSon Pharma, a renowned name in pharmaceutical sector, has build high its reputation as a complete solution provider in contract research arena. We are leading manufacturer and supplier of pharmaceutical Reference materials like Drug working standard, Drug impurity standards, Drug metabolites and Stable Isotope Labelled compounds. Our expertise in this area has made us one of the the most trusted companies in the industry. We are the front runner in manufacturing complicated Drug impurity standards or Reference materials and the complete solution provider in identifying, synthesizing and qualifying any Unknown impurity. We have scaled up our operations to make the company a holistic solution provider and would be supplying all reference chemicals and materials for research requirements . In short, we are one stop solutions for Chemical development, Formulation development, Analytical development and Regulatory services. SimSon Pharma not only synthesize and supply molecules but also provides cost effective & innovative approach to help companies achieve success. We work closely with our clients for understanding their requirements and offer them time bound solutions. Vision: To become a leading pharma company and a preferred partner for the global pharma industry for Reference materials, Research chemicals and R&D services. Mission: We strive to provide a cost-effective and time-bound research solutions in the area of custom synthesis, formulation development and analytical development."
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1643567400,"product":"XANOMELINE TARTRATE (QTY:570.910 KGS)","address":"SANALI INFO PARK, 8-2-120\/113,ROAD NO.2, BANJARA HILLS","city":"HYDERABAD,TELANGANA","supplier":"NEULAND LABORATORIES","supplierCountry":"INDIA","foreign_port":"NEW YORK - JOHN F. K","customer":"TO THE ORDER OF","customerCountry":"UNITED STATES","quantity":"570.91","actualQuantity":"570.91","unit":"KGS","unitRateFc":"2511","totalValueFC":"1416366.2","currency":"USD","unitRateINR":184810.21527035785,"date":"31-Jan-2022","totalValueINR":"105510000","totalValueInUsd":"1416366.2","indian_port":"HYDERABAD AIR","hs_no":"29181390","bill_no":"7882755","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"SANALI INFO PARK, 8-2-120\/113,ROAD NO.2, BANJARA HILLS, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1661797800,"product":"XANOMELINE TARTRATE","address":"SANALI INFO PARK, 8-2-120\/113,ROAD NO.2, BANJARA HILLS","city":"HYDERABAD,TELANGANA","supplier":"NEULAND LABORATORIES","supplierCountry":"INDIA","foreign_port":"CHICAGO O\\'HARE INT\\'L","customer":"TO THE ORDER OF","customerCountry":"UNITED STATES","quantity":"579.00","actualQuantity":"579","unit":"KGS","unitRateFc":"2511","totalValueFC":"1439852.9","currency":"USD","unitRateINR":197867.01208981001,"date":"30-Aug-2022","totalValueINR":"114565000","totalValueInUsd":"1439852.9","indian_port":"HYDERABAD AIR","hs_no":"29181390","bill_no":"3851937","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"SANALI INFO PARK, 8-2-120\/113,ROAD NO.2, BANJARA HILLS, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1676572200,"product":"XANOMELINE TARTRATE","address":"SANALI INFO PARK, 8-2-120\/113,ROAD NO.2, BANJARA HILLS","city":"HYDERABAD,TELANGANA","supplier":"NEULAND LABORATORIES","supplierCountry":"INDIA","foreign_port":"CHICAGO O\\'HARE INT\\'L","customer":"TO THE ORDER OF,","customerCountry":"UNITED STATES","quantity":"603.20","actualQuantity":"603.2","unit":"KGS","unitRateFc":"1800","totalValueFC":"1076691.8","currency":"USD","unitRateINR":147420.42440318302,"date":"17-Feb-2023","totalValueINR":"88924000","totalValueInUsd":"1076691.8","indian_port":"HYDERABAD AIR","hs_no":"29181390","bill_no":"7867768","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"SANALI INFO PARK, 8-2-120\/113,ROAD NO.2, BANJARA HILLS, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1698345000,"product":"XANOMELINE TARTRATE","address":"SANALI INFO PARK, A BLOCK","city":"ROAD NO.2, BANJARA HILLS, HYDERABAD","supplier":"NEULAND LABORATORIES","supplierCountry":"INDIA","foreign_port":"PHILADELPHIA METROP","customer":"TO THE ORDER OF","customerCountry":"UNITED STATES","quantity":"2453.94","actualQuantity":"2453.94","unit":"KGS","unitRateFc":"1800","totalValueFC":"4375730.8","currency":"USD","unitRateINR":148409.90407263421,"date":"27-Oct-2023","totalValueINR":"364189000","totalValueInUsd":"4375730.8","indian_port":"Hyderabad Air","hs_no":"29181390","bill_no":"4928543","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"SANALI INFO PARK, A BLOCK, ROAD NO.2, BANJARA HILLS, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725215400,"product":"XANOMELINE TARTRATE","address":"SANALI INFO PARK, A BLOCK","city":"ROAD NO.2, BANJARA HILLS, HYDERABAD","supplier":"NEULAND LABORATORIES","supplierCountry":"INDIA","foreign_port":"MANCHESTER, NH","customer":"DHL SUPPLY CHAIN","customerCountry":"UNITED STATES","quantity":"1821.86","actualQuantity":"1821.86","unit":"KGS","unitRateFc":"1800","totalValueFC":"3251907.4","currency":"USD","unitRateINR":149580.00000000003,"date":"02-Sep-2024","totalValueINR":"272513818.8","totalValueInUsd":"3251907.4","indian_port":"Hyderabad Air","hs_no":"29181390","bill_no":"3690714","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"SANALI INFO PARK, A BLOCK, ROAD NO.2, BANJARA HILLS, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725215400,"product":"XANOMELINE TARTRATE","address":"SANALI INFO PARK, A BLOCK","city":"ROAD NO.2, BANJARA HILLS, HYDERABAD","supplier":"NEULAND LABORATORIES","supplierCountry":"INDIA","foreign_port":"MANCHESTER, NH","customer":"DHL SUPPLY CHAIN","customerCountry":"UNITED STATES","quantity":"1821.86","actualQuantity":"1821.86","unit":"KGS","unitRateFc":"1800","totalValueFC":"3251907.4","currency":"USD","unitRateINR":149580.00000000003,"date":"02-Sep-2024","totalValueINR":"272513818.8","totalValueInUsd":"3251907.4","indian_port":"Hyderabad Air","hs_no":"29181390","bill_no":"3701233","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"SANALI INFO PARK, A BLOCK, ROAD NO.2, BANJARA HILLS, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725820200,"product":"XANOMELINE TARTRATE","address":"SANALI INFO PARK, A BLOCK","city":"ROAD NO.2, BANJARA HILLS, HYDERABAD","supplier":"NEULAND LABORATORIES","supplierCountry":"INDIA","foreign_port":"MANCHESTER, NH","customer":"DHL SUPPLY CHAIN","customerCountry":"UNITED STATES","quantity":"1798.67","actualQuantity":"1798.67","unit":"KGS","unitRateFc":"1800","totalValueFC":"3212446.4","currency":"USD","unitRateINR":149669.99999999997,"date":"09-Sep-2024","totalValueINR":"269206938.9","totalValueInUsd":"3212446.4","indian_port":"Hyderabad Air","hs_no":"29181390","bill_no":"3868416","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"SANALI INFO PARK, A BLOCK, ROAD NO.2, BANJARA HILLS, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1726684200,"product":"XANOMELINE TARTRATE","address":"SANALI INFO PARK, A BLOCK","city":"ROAD NO.2, BANJARA HILLS, HYDERABAD","supplier":"NEULAND LABORATORIES","supplierCountry":"INDIA","foreign_port":"MANCHESTER, NH","customer":"DHL SUPPLY CHAIN","customerCountry":"UNITED STATES","quantity":"1830.34","actualQuantity":"1830.34","unit":"KGS","unitRateFc":"1800","totalValueFC":"3269009.4","currency":"USD","unitRateINR":149670,"date":"19-Sep-2024","totalValueINR":"273946987.8","totalValueInUsd":"3269009.4","indian_port":"Hyderabad Air","hs_no":"29181390","bill_no":"4166238","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"SANALI INFO PARK, A BLOCK, ROAD NO.2, BANJARA HILLS, HYDERABAD","customerAddress":""}]
31-Jan-2022
19-Sep-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more

Details:

KarXT (xanomeline-trospium) is an oral, investigational M1/M4-preferring muscarinic agonist in development for the treatment of psychiatric and neurological conditions, including schizophrenia.


Lead Product(s): Xanomeline,Trospium Chloride

Therapeutic Area: Psychiatry/Psychology Brand Name: KarXT

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable October 29, 2024

blank

01

Zai Lab

China
arrow
CPHI Middle east
Not Confirmed

Zai Lab

China
arrow
CPHI Middle east
Not Confirmed

Details : KarXT (xanomeline-trospium) is an oral, investigational M1/M4-preferring muscarinic agonist in development for the treatment of psychiatric and neurological conditions, including schizophrenia.

Brand Name : KarXT

Molecule Type : Small molecule

Upfront Cash : Not Applicable

October 29, 2024

blank

Details:

Cobenfy (xanomeline-trospium) is an oral, investigational M1/M4 agonist indcated for psychiatric and neurological conditions, including schizophrenia.


Lead Product(s): Xanomeline,Trospium

Therapeutic Area: Psychiatry/Psychology Brand Name: Cobenfy

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 26, 2024

blank

02

CPHI Middle east
Not Confirmed
CPHI Middle east
Not Confirmed

Details : Cobenfy (xanomeline-trospium) is an oral, investigational M1/M4 agonist indcated for psychiatric and neurological conditions, including schizophrenia.

Brand Name : Cobenfy

Molecule Type : Small molecule

Upfront Cash : Not Applicable

September 26, 2024

blank

Details:

KarXT (xanomeline-trospium) is an investigational oral muscarinic agonist targeting psychiatric and neurological conditions like schizophrenia and Alzheimer’s psychosis.


Lead Product(s): Xanomeline,Trospium Chloride

Therapeutic Area: Psychiatry/Psychology Brand Name: KarXT

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable April 06, 2024

blank

03

CPHI Middle east
Not Confirmed
CPHI Middle east
Not Confirmed

Details : KarXT (xanomeline-trospium) is an investigational oral muscarinic agonist targeting psychiatric and neurological conditions like schizophrenia and Alzheimer’s psychosis.

Brand Name : KarXT

Molecule Type : Small molecule

Upfront Cash : Not Applicable

April 06, 2024

blank

Details:

BMS acquires KarXT (xanomeline-trospium), an M1/M4 receptor agonist, for treating schizophrenia, enhancing its development.


Lead Product(s): Xanomeline,Trospium Chloride

Therapeutic Area: Psychiatry/Psychology Brand Name: KarXT

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Bristol Myers Squibb

Deal Size: $14,000.0 million Upfront Cash: $14,000.0 million

Deal Type: Acquisition March 18, 2024

blank

04

CPHI Middle east
Not Confirmed
CPHI Middle east
Not Confirmed

Details : BMS acquires KarXT (xanomeline-trospium), an M1/M4 receptor agonist, for treating schizophrenia, enhancing its development.

Brand Name : KarXT

Molecule Type : Small molecule

Upfront Cash : $14,000.0 million

March 18, 2024

blank

Details:

Through the acquisition, BMS will enhance the development of KarXT (xanomeline-trospium), an antipsychotic with a novel mechanism of being a first-in-class M1 / M4 muscarinic receptor agonist, with differentiated efficacy and safety for treating schizophrenia in adults.


Lead Product(s): Xanomeline,Trospium Chloride

Therapeutic Area: Psychiatry/Psychology Brand Name: KarXT

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Bristol Myers Squibb

Deal Size: $14,000.0 million Upfront Cash: $14,000.0 million

Deal Type: Acquisition December 22, 2023

blank

05

CPHI Middle east
Not Confirmed
CPHI Middle east
Not Confirmed

Details : Through the acquisition, BMS will enhance the development of KarXT (xanomeline-trospium), an antipsychotic with a novel mechanism of being a first-in-class M1 / M4 muscarinic receptor agonist, with differentiated efficacy and safety for treating schizoph...

Brand Name : KarXT

Molecule Type : Small molecule

Upfront Cash : $14,000.0 million

December 22, 2023

blank

Details:

KarXT (xanomeline and trospium chloride) is an M1/M4 receptor Agonist small molecule drug delivered orally in capsule form for the treatment of Schizophrenia.


Lead Product(s): Xanomeline,Trospium Chloride

Therapeutic Area: Psychiatry/Psychology Brand Name: KarXT

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable November 29, 2023

blank

06

CPHI Middle east
Not Confirmed
CPHI Middle east
Not Confirmed

Details : KarXT (xanomeline and trospium chloride) is an M1/M4 receptor Agonist small molecule drug delivered orally in capsule form for the treatment of Schizophrenia.

Brand Name : KarXT

Molecule Type : Small molecule

Upfront Cash : Not Applicable

November 29, 2023

blank

Details:

KarXT (xanomeline-trospium) is an oral, investigational M1/M4-preferring muscarinic agonist in development for the treatment of psychiatric and neurological conditions, including schizophrenia and psychosis in Alzheimer’s disease.


Lead Product(s): Xanomeline,Trospium Chloride

Therapeutic Area: Psychiatry/Psychology Brand Name: KarXT

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable November 17, 2023

blank

07

CPHI Middle east
Not Confirmed
CPHI Middle east
Not Confirmed

Details : KarXT (xanomeline-trospium) is an oral, investigational M1/M4-preferring muscarinic agonist in development for the treatment of psychiatric and neurological conditions, including schizophrenia and psychosis in Alzheimer’s disease.

Brand Name : KarXT

Molecule Type : Small molecule

Upfront Cash : Not Applicable

November 17, 2023

blank

Details:

KarXT (xanomeline-trospium) is an oral, investigational M1/M4-preferring muscarinic agonist in development for the treatment of psychiatric and neurological conditions, including schizophrenia and psychosis in Alzheimer’s disease.


Lead Product(s): Xanomeline,Trospium Chloride

Therapeutic Area: Psychiatry/Psychology Brand Name: KarXT

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable November 16, 2023

blank

08

CPHI Middle east
Not Confirmed
CPHI Middle east
Not Confirmed

Details : KarXT (xanomeline-trospium) is an oral, investigational M1/M4-preferring muscarinic agonist in development for the treatment of psychiatric and neurological conditions, including schizophrenia and psychosis in Alzheimer’s disease.

Brand Name : KarXT

Molecule Type : Small molecule

Upfront Cash : Not Applicable

November 16, 2023

blank

Details:

KarXT (xanomeline-trospium) is an oral, investigational M1/M4-preferring muscarinic agonist in development for the treatment of psychiatric and neurological conditions, including schizophrenia and psychosis in Alzheimer’s disease.


Lead Product(s): Xanomeline,Trospium Chloride

Therapeutic Area: Psychiatry/Psychology Brand Name: KarXT

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Karuna Therapeutics

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 28, 2023

blank

09

CPHI Middle east
Not Confirmed
CPHI Middle east
Not Confirmed

Details : KarXT (xanomeline-trospium) is an oral, investigational M1/M4-preferring muscarinic agonist in development for the treatment of psychiatric and neurological conditions, including schizophrenia and psychosis in Alzheimer’s disease.

Brand Name : KarXT

Molecule Type : Small molecule

Upfront Cash : Not Applicable

September 28, 2023

blank

Details:

The proceedings will be used to fund Karuna's ongoing and planned clinical trials of KarXT (xanomeline), to support the potential commercialization of KarXT for psychosis in schizophrenia, to support and expand company's pipeline of clinical and preclinical programs.


Lead Product(s): Xanomeline,Trospium Chloride

Therapeutic Area: Psychiatry/Psychology Brand Name: KarXT

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Goldman Sachs & Co. LLC

Deal Size: $460.0 million Upfront Cash: Undisclosed

Deal Type: Public Offering March 24, 2023

blank

10

CPHI Middle east
Not Confirmed
CPHI Middle east
Not Confirmed

Details : The proceedings will be used to fund Karuna's ongoing and planned clinical trials of KarXT (xanomeline), to support the potential commercialization of KarXT for psychosis in schizophrenia, to support and expand company's pipeline of clinical and preclini...

Brand Name : KarXT

Molecule Type : Small molecule

Upfront Cash : Undisclosed

March 24, 2023

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

STOCK RECAP #PipelineProspector

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty